Kidney Complications from Cancer Drugs in Japan
Author Information
Author(s): Kuwabara Takashige, Miyasato Yoshikazu, Kanki Tomoko, Mizumoto Teruhiko, Matsubara Takeshi, Sawa Naoki, Sugiyama Hitoshi, Maruyama Shoichi, Sato Hiroshi, Tsukamoto Tatsuo, Murata Tomohiro, Miyazaki Mariko, Imasawa Toshiyuki, Mukoyama Masashi, Murakami Naoka, Jhaveri Kenar D, Yanagita Motoko
Primary Institution: Kumamoto University Graduate School of Medical Sciences
Hypothesis
What are the real-world clinical outcomes of anticancer drug therapy–associated renal complications in Japan?
Conclusion
The study found that kidney complications from anticancer drugs are common and can lead to worse outcomes, particularly in cases of thrombotic microangiopathy.
Supporting Evidence
- Thrombotic microangiopathy (TMA) was found in 35.6% of cases.
- Tubulointerstitial nephritis (TIN) was the most common diagnosis at 47.4%.
- Proton pump inhibitor (PPI) use was identified as a significant prognostic factor.
- Overall survival was worse in cytotoxic agent–associated TMA compared to other TMAs.
- Antibiotics were more frequently used in TMA cases compared to others.
Takeaway
This study looked at how cancer drugs can hurt people's kidneys and found that some types of kidney problems are more common and serious than others.
Methodology
The study analyzed 135 confirmed anticancer drug-related cases from a national kidney biopsy database, using statistical methods to evaluate survival rates and associations with various factors.
Potential Biases
Potential bias due to the nature of kidney biopsies being performed in cases suspected of having specific kidney complications.
Limitations
The study may have selection bias as kidney biopsies are more likely performed in cases with expected favorable prognosis, and the small sample size may limit the generalizability of the findings.
Participant Demographics
The study included 135 participants, predominantly male (60.7%), with a median age of 68 years; 26% had diabetes and 59% were on antihypertensive therapy.
Statistical Information
P-Value
p<0.001 for antibiotic use in TMA cases
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website